COVID-19 vaccination for children with cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
There has been a rapid global response in vaccine development since declaration of the COVID-19 pandemic in March 2020. Data are beginning to emerge establishing the safety, tolerability, immunogenicity and efficacy of COVID-19 vaccines in children and adolescents.1, 2 While children and adolescents infected with SARS-CoV-2 suffer from milder illness than adults, those with underlying health co-morbidities, including cancer, can suffer from severe disease.3, 4 Minimizing risk of exposure remains important in reducing the risk of SARS-CoV-2 infection in children with cancer,5 however vaccination is emerging as a critical strategy for prevention of infection, reducing severity of disease and contributing to herd immunity.